Misleading marketing and incomplete scientific data have led to widespread misinformation about botulinum toxin products.
Andy Curry, PhD
Advertisement
Articles by Andy Curry, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
How Approvals, Setbacks, and a Crowded Pipeline Are Reshaping the AD Treatment Landscape
2
ORKA-001 Achieves 61% Complete Skin Clearance in Psoriasis
3
ATI-052 Shows Rapid Improvements in Atopic Dermatitis
4
FDA Revises TB Evaluation Guidance for SKYRIZI
5